GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

The FDA wants bulk production of copycat versions of popular weight-loss drugs to stop, but telehealth companies and compounding pharmacies ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight loss ...

Being listed by the US government as a “sensitive” country, South Korea will experience complications in potential ...

These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...

The FBI has issued a warning about counterfeit versions of compounded weight loss drugs, which have been found to contain "unknown drugs, hig ...

The end of compounded versions of weight-loss drugs is near, leaving patients scrambling for alternatives. Some “copycat” ...

People nationwide who can’t afford the name-brand drugs, which can cost more than $1,000 a month, have been flocking to pharmacies or telehealth companies like Hims & Hers to buy compounded ...